tradingkey.logo
tradingkey.logo
検索

Baxter International Inc

BAX
ウォッチリストに追加
21.550USD
+0.510+2.42%
終値 06/25, 16:00ET15分遅れの株価
11.13B時価総額
損失額直近12ヶ月PER

詳細情報 Baxter International Inc 企業名

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Baxter International Incの企業情報

企業コードBAX
会社名Baxter International Inc
上場日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)
従業員数38000
証券種類Ordinary Share
決算期末Jun 20
本社所在地One Baxter Parkway
都市DEERFIELD
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号60015
電話番号12249482000
ウェブサイトhttps://www.baxter.com/
企業コードBAX
上場日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)

Baxter International Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%

よくある質問

Baxter International Incの上位5名の株主は誰ですか?

Baxter International Incの上位5名の株主は以下のとおりです。Mr. Andrew P. Hider

Baxter International Inc(BAX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Baxter International Incの株式を保有している機関は1767社あり、保有株式の総市場価値は約557.84Mで、全体の108.01%を占めています。2025Q4と比較して、機関の持ち株は-45350754.00増加しています。

Baxter International Incの最大の収益源は何ですか?

2026Q1において、Infusion Therapies and Technologies部門がBaxter International Incにとって最大の収益を生み出しており、その金額は4.10Bで、全収益の36.47%を占めています。
KeyAI